The management of MeCure Industries Plc has assured that the company is focused on deepening local manufacturing, improving access to quality medicines, expanding its product pipeline and delivering value to shareholders as it enters the second half of 2026.
The company gave the assurance as it closed the first half of 2026 on a strong note, marked by the affirmation of its national-scale issuer ratings by GCR Ratings, the award of Halal certification, and launch of two new products.
The rating agency’s decision was supported by improvements in MeCure’s competitive position, sound earnings performance, ongoing expansion, product innovation, and wider market penetration.
READ ALSO: FG approves $1.28bn Seplat-ExxonMobil deal
It also noted the company’s diversified portfolio of more than 140 formulations across five therapeutic classes, its extensive distribution network, and relationships with suppliers and technical partners.
During the period, MeCure also received Halal certification, reinforcing the firm’s commitment to quality, compliance, and broader consumer accessibility.
The company’s management described the Halal certification as evidence that the certified products had been reviewed to ensure that their ingredients, sourcing, handling, and production processes comply with recognised Halal requirements.
Edo Governor, Monday Okpebholo, on Friday, lauded the foundation for the construction of an ultra-modern…
Leader of INRI Evangelical Spiritual Church, Primate Elijah Ayodele, has warned President Bola Ahmed Tinubu’s…
The 2026 national ranking of Nigerian tertiary institutions is progressing satisfactorily and will culminate in…
The Ekiti State Police Command has confirmed an attack on the presidential candidate of the…
Ekiti State Governor, Biodun Oyebanji, has charged members of the All Progressives Congress (APC) Presidential…
Allied Peoples Movement (APM) House of Representatives candidate for Oluyole Federal Constituency, Engr. Akeem Olatunji,…
This website uses cookies.